Thiard News@F4F

@newsen.bsky.social

13 hours ago

National Proton Conference 2026 Highlights Progress in Proton Therapy and Enhanced Accessibility The 2026 National Proton Conference showcased significant advances in proton therapy, focusing on survival rates and accessibility for younger cancer patients.

National Proton Conference 2026 Highlights Progress in Proton Therapy and Enhanced Accessibility #United_States #Nashville #Cancer_Treatment #Proton_Therapy #NAPT

Thiard News@F4F

@newsen.bsky.social

19 hours ago

DualityBio's Trastuzumab Pamirtecan Accepted by NMPA for Breast Cancer Treatment DualityBio announces that the NMPA has accepted its application for Trastuzumab Pamirtecan, aiming to treat HER2-positive breast cancer in adults. This is a major step towards improving treatment options.

DualityBio's Trastuzumab Pamirtecan Accepted by NMPA for Breast Cancer Treatment #China #Shanghai #Cancer_Treatment #DualityBio #Trastuzumab_Pamirtecan

Thiard News@F4F

@newsen.bsky.social

1 day ago

ImmunityBio Faces Serious Legal Challenges and Market Drop Over Misleading Drug Claims ImmunityBio, Inc. faces a class action over misleading claims about its cancer treatment, leading to a significant market drop and FDA scrutiny.

ImmunityBio Faces Serious Legal Challenges and Market Drop Over Misleading Drug Claims #USA #San_Francisco #Cancer_Treatment #ImmunityBio #IBRX

Thiard News@F4F

@newsen.bsky.social

1 day ago

Eascra Biotech's Revolutionary Nanomedicine for Targeting Tough Tumors Eascra Biotech is set to innovate cancer treatment using nanomedicine developed in space research for targeting challenging tumors effectively.

Eascra Biotech's Revolutionary Nanomedicine for Targeting Tough Tumors #USA #Cancer_Treatment #Florida #Eascra_Biotech #Janus_Nanomaterials

Thiard News@F4F

@newsen.bsky.social

1 day ago

Dr. Nancy L. Lewis Appointed as Chief Scientific Officer of NCCN to Enhance Cancer Research and Treatment The National Comprehensive Cancer Network has appointed Dr. Nancy L. Lewis as its new Chief Scientific Officer. Her expertise aims to improve cancer treatment programs and clinical trials.

Dr. Nancy L. Lewis Appointed as Chief Scientific Officer of NCCN to Enhance Cancer Research and Treatment #USA #Cancer_Treatment #Plymouth_Meeting #NCCN #Dr._Nancy_L._Lewis

Thiard News@F4F

@newsen.bsky.social

3 days ago

Lumonus Partners with Leading Cancer Center to Enhance Radiation Therapy Planning Lumonus announces collaboration with Memorial Sloan Kettering Cancer Center to refine radiation therapy treatment planning. This partnership aims to enhance automated processes and improve patient outcomes.

Lumonus Partners with Leading Cancer Center to Enhance Radiation Therapy Planning #USA #New_York #Cancer_Treatment #Lumonus #ECHO_Engine

Thiard News@F4F

@newsen.bsky.social

4 days ago

Advancements in Personalized Cancer Immunotherapy at Pan Am Cancer Centers Pan Am Cancer Treatment Centers enhances its global leadership in cancer immunotherapy through collaboration with Dr. Baofa Yu, introducing groundbreaking ImmunoSurgery protocols.

Advancements in Personalized Cancer Immunotherapy at Pan Am Cancer Centers #United_States #San_Diego #Cancer_Treatment #ImmunoSurgery #Baofa_Yu

Thiard News@F4F

@newsen.bsky.social

4 days ago

Accuray Appoints Paul Miele as Chief Commercial Officer for Continued Growth Accuray Incorporated announces the appointment of Paul Miele as Chief Commercial Officer, enhancing its leadership team for global expansion in cancer treatment technology.

Accuray Appoints Paul Miele as Chief Commercial Officer for Continued Growth #United_States #Cancer_Treatment #Madison #Accuray #Paul_Miele

Thiard News@F4F

@newsen.bsky.social

4 days ago

Kowa Company Unveils K-679: A Breakthrough in Cancer Treatment with Innovative Drug-Loaded Antibody Conjugate Kowa Company, Ltd. announces K-679, a game-changing antibody-drug conjugate that promises enhanced efficacy and selectivity against tumors in preclinical models.

Kowa Company Unveils K-679: A Breakthrough in Cancer Treatment with Innovative Drug-Loaded Antibody Conjugate #Japan #Nagoya #Cancer_Treatment #K-679 #Kowa_Company

Thiard News@F4F

@newsen.bsky.social

1 week ago

The Prefilled Syringes Market: Growth to $14.53 Billion by 2031 The prefilled syringes market is projected to grow significantly, reaching $14.53 billion by 2031, driven by technological advancements and rising chronic diseases.

The Prefilled Syringes Market: Growth to $14.53 Billion by 2031 #USA #Cancer_Treatment #Delray_Beach #MarketsandMarkets #Prefilled_Syringes

Thiard News@F4F

@newsen.bsky.social

2 weeks ago

CStone Pharmaceuticals Unveils Exciting New Data for CS2009, a Trispecific Antibody in Cancer Treatment CStone Pharmaceuticals announces promising Phase I/II data for CS2009, a trispecific antibody targeting cancer, showing excellent safety and efficacy in trials.

CStone Pharmaceuticals Unveils Exciting New Data for CS2009, a Trispecific Antibody in Cancer Treatment #Cancer_Treatment #CStone_Pharmaceuticals #CS2009

Thiard News@F4F

@newsen.bsky.social

2 weeks ago

Peptide Therapeutics Market Set for Remarkable Growth, Projected to Reach $70.20 Billion by 2031 The peptide therapeutics market is expected to expand significantly, driven by increased cancer cases and metabolic disorders, valued at $70.20 billion by 2031.

Peptide Therapeutics Market Set for Remarkable Growth, Projected to Reach $70.20 Billion by 2031 #India #Market_Growth #Cancer_Treatment #Hyderabad #Peptide_Therapeutics

Thiard News@F4F

@newsen.bsky.social

3 weeks ago

Diakonos Oncology to Present Groundbreaking Data on DOC1021 in Cancer Treatment at 2026 Conferences Diakonos Oncology Corp. will unveil clinical trial results for DOC1021, an innovative immunotherapy for pancreatic cancer and glioblastoma, at AACR and AAN 2026.

Diakonos Oncology to Present Groundbreaking Data on DOC1021 in Cancer Treatment at 2026 Conferences #United_States #Houston #Cancer_Treatment #Diakonos_Oncology #DOC1021

Thiard News@F4F

@newsen.bsky.social

4 weeks ago

Significant Growth Expected for Radioligand Therapies Market by 2034 Amid Cancer Treatment Innovations The radioligand therapies market is projected for substantial growth as cancer cases rise and innovative treatments become available, impacting healthcare significantly.

Significant Growth Expected for Radioligand Therapies Market by 2034 Amid Cancer Treatment Innovations #USA #Las_Vegas #Cancer_Treatment #Novartis #Radioligand_Therapies

Thiard News@F4F

@newsen.bsky.social

4 weeks ago

Aethlon Medical Partners with Maxim Group to Explore New Strategies Aethlon Medical has enlisted Maxim Group as its financial advisor to assess strategic opportunities. The company is focusing on potential partnerships and acquisitions.

Aethlon Medical Partners with Maxim Group to Explore New Strategies #United_States #San_Diego #Cancer_Treatment #Aethlon_Medical #Maxim_Group

Thiard News@F4F

@newsen.bsky.social

1 month ago

Engage with Experts at Karmanos' Community Conversations on Cancer 2026 Join the Karmanos Cancer Institute's Community Conversations on Cancer series for insightful discussions with experts about cancer diagnosis and treatment in 2026.

Engage with Experts at Karmanos' Community Conversations on Cancer 2026 #USA #Detroit #Cancer_Treatment #Karmanos_Cancer_Institute #Community_Conversations

Thiard News@F4F

@newsen.bsky.social

1 month ago

South University and Calvary Clinic Join Forces for Vital Cancer Care Access South University in Tampa collaborates with Calvary Community Clinic to ensure cancer treatment for an uninsured patient, showcasing real-world impact.

South University and Calvary Clinic Join Forces for Vital Cancer Care Access #United_States #Cancer_Treatment #Tampa #South_University #Calvary_Clinic

Thiard News@F4F

@newsen.bsky.social

1 month ago

Companion Diagnostics Market Expected to Grow Significantly by 2032 Amid Rising Cancer Cases The companion diagnostics market is poised for robust growth driven by rising cancer rates and advancements in precision medicine, with projections reaching $12 billion by 2032.

Companion Diagnostics Market Expected to Grow Significantly by 2032 Amid Rising Cancer Cases #None #Cancer_Treatment #Precision_Medicine #Companion_Diagnostics

Thiard News@F4F

@newsen.bsky.social

1 month ago

Cadonilimab Shows Promising Long-Term Survival Rates in R/M Cervical Cancer Patients Akeso, Inc. reports remarkable 24-month overall survival rates for cadonilimab-treated cervical cancer patients, reshaping treatment protocols.

Cadonilimab Shows Promising Long-Term Survival Rates in R/M Cervical Cancer Patients #China #Hong_Kong #Cancer_Treatment #Akeso #Cadonilimab

Pankaj

@pankajayurveda.bsky.social

1 month ago

Top 5 Cancer Hospitals in Andheri: Services, Specialties & Reviews The top 5 cancer hospitals in Andheri include Kokilaben Dhirubhai Ambani Hospital - Andheri West, Holy Spirit Hospital - Andheri East, Seven..

five known #hospitals that provide #cancer_treatment in Andheri, so you can compare and decide calmly.

hiims.in/hospital/mum...

Thiard News@F4F

@newsen.bsky.social

1 month ago

Biliary Tract Cancer Market Anticipates Explosive Growth at 10.1% CAGR Through 2034 The biliary tract cancer market is expected to grow at a CAGR of 10.1% from 2025 to 2034, driven by rising incidences and innovative treatments.

Biliary Tract Cancer Market Anticipates Explosive Growth at 10.1% CAGR Through 2034 #United_States #Las_Vegas #Cancer_Treatment #DelveInsight #biliary_tract_cancer

Thiard News@F4F

@newsen.bsky.social

1 month ago

Precision Biologics to Present Novel Monoclonal Antibodies at Festival of Biologics USA Precision Biologics will showcase groundbreaking monoclonal antibodies targeting cancer-specific markers at the Festival of Biologics USA in San Diego.

Precision Biologics to Present Novel Monoclonal Antibodies at Festival of Biologics USA #USA #San_Diego #Cancer_Treatment #Monoclonal_Antibodies #Precision_Biologics

Thiard News@F4F

@newsen.bsky.social

1 month ago

International Consortium Wins Bial Award for Groundbreaking Cancer Treatment Research Involving Gut Bacteria An international team has received the Bial Award for their significant research linking gut microbiome health to cancer treatment efficacy, shedding light on immunotherapy.

International Consortium Wins Bial Award for Groundbreaking Cancer Treatment Research Involving Gut Bacteria #Cancer_Treatment #Portugal #Porto #Gut_Microbiome #BIAL_Award

Thiard News@F4F

@newsen.bsky.social

1 month ago

Antengene and Junshi Biosciences Collaborate to Enhance Cancer Treatment Using ATG-037 and JS207 Antengene partners with Junshi Biosciences to investigate ATG-037 and JS207's combined potential in treating solid tumors, promising new therapies.

Antengene and Junshi Biosciences Collaborate to Enhance Cancer Treatment Using ATG-037 and JS207 #Cancer_Treatment #Antengene #Junshi_Biosciences

Thiard News@F4F

@newsen.bsky.social

1 month ago

Okayama University Introduces Groundbreaking PSMA Lutetium Therapy for Advanced Prostate Cancer Okayama University is implementing innovative PSMA Lutetium therapy for difficult-to-treat metastatic castration-resistant prostate cancer patients, offering hope and improved quality of life.

Okayama University Introduces Groundbreaking PSMA Lutetium Therapy for Advanced Prostate Cancer #Japan #Cancer_Treatment #Okayama #Okayama_University #PSMA_Lutetium

Thiard News@F4F

@newsen.bsky.social

1 month ago

Maryland Proton Treatment Center Marks Decade of Hope and Healing Through Proton Therapy Celebrating ten years of excellence, the Maryland Proton Treatment Center honors its patients and staff for providing advanced cancer treatment through proton therapy.

Maryland Proton Treatment Center Marks Decade of Hope and Healing Through Proton Therapy #USA #Baltimore #Cancer_Treatment #Proton_Therapy #Maryland_Proton

Thiard News@F4F

@newsen.bsky.social

1 month ago

Research Advances: Making Immune Checkpoint Inhibitors Safer for Cancer Patients New findings from Cincinnati Children's Hospital show potential to reduce heart-related side effects from immune checkpoint inhibitors, boosting cancer treatment safety.

Research Advances: Making Immune Checkpoint Inhibitors Safer for Cancer Patients #United_States #Cancer_Treatment #Cincinnati #Cincinnati_Children's #Immune_Checkpoint_Inhibitors

Thiard News@F4F

@newsen.bsky.social

1 month ago

Revolutionary EXO 001 Exosome Platform Offers New Hope for Solid Tumor Treatment The groundbreaking EXO 001 exosome platform by China Medical University Hospital and Ever Supreme Bio Technology provides a novel treatment for solid tumors, showing remarkable preclinical success.

Revolutionary EXO 001 Exosome Platform Offers New Hope for Solid Tumor Treatment #Taiwan #Cancer_Treatment #CAR-T_therapy #Taichung #EXO_001

Thiard News@F4F

@newsen.bsky.social

1 month ago

The Growing BCL-2 Inhibitors Market: Key Trends and Prognosis for 2025-2034 The BCL-2 inhibitors market is on the rise, driven by increasing cancer cases and the advent of innovative therapies. Discover how this sector is shaping up until 2034.

The Growing BCL-2 Inhibitors Market: Key Trends and Prognosis for 2025-2034 #United_States #Las_Vegas #Cancer_Treatment #oncology_research #BCL-2_Inhibitors

Thiard News@F4F

@newsen.bsky.social

2 months ago

Akso Health Group Launches Global Patient Support Initiative to Enhance Cancer Treatment Accessibility Akso Health Group is launching an innovative patient support initiative aimed at improving accessibility to cancer treatment through global resource integration.

Akso Health Group Launches Global Patient Support Initiative to Enhance Cancer Treatment Accessibility #China #Qingdao #Cancer_Treatment #Patient_Support #Akso_Health